Dr. Janice Faulknor is a 15-year veteran in clinical research on CNS products, Human Abuse Potential (HAP) and Abuse Deterrent Assessment programs. Having conducted over 100+ Phase1/HAL trials over her 8-year tenure as PI/Sub-I with BioPharma Services, Dr. Faulknor is an industry leader, and a key member of the BPSI medical team. Dr. Faulknor gained her medical degree from the McMaster University in 1996 with a specialty in Family Medicine and continues to practise today.
Recent Posts
- Pride in Research: Celebrating Inclusion and Diversity at BioPharma
- Health Canada Confirms BioPharma Services Inc. in Full Compliance Following Successful QI Inspection
- Addressing Eight Misconceptions About Clinical Trials in Canada
- Role of the Institutional Review Boards (IRBs) at a Phase 1 CRO
- Bioequivalence Studies: Designing an Effective Sampling Schedule
Recent Comments